Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03664609 · ClinicalTrials.gov registry record
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
A clinical trial of Parkinson Disease and Essential Tremor, sponsored by Boston Scientific Corporation.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 19
- Study locations
NCT03664609: Recruiting study of Parkinson Disease and Essential Tremor, sponsored by Boston Scientific Corporation.
NCT03664609 is a study of Parkinson Disease and Essential Tremor that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 5,000 participants, roughly in line with the 5,310-participant average among 297 other Parkinson Disease trials with a reported enrollment target. The trial reports 19 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03664609, a study of Parkinson Disease and Essential Tremor, is actively recruiting participants, sponsored by Boston Scientific Corporation.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 19
- Study locations
Study Summary
The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
Primary Outcome
Improvement in disease symptoms as assessed by Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline
Conditions Studied
Interventions
- DEVICE Deep Brain Stimulation
Study Locations (19)
Other
- AZ St. Lucas - Ghent
- AZ Delta - Roeselare
- Hopital Fondation Adolphe de Rothschild - Paris
- Uniklinik Köln - Cologne
- Universitaetsklinikum Dusseldorf - Düsseldorf
- Uniklinikum Jena - Jena
- Universitaetsklinikum Schleswig-Holstein - Lübeck
- Universitaetsklinikum Wuerzburg - Würzburg
- Fondazione Istituto Neurologico Casimiro Mondino - Pavia
- Hospital Virgen Del Rocio - Seville
Florida
- University of Miami Hospital - Miami
- University of South Florida - Tampa
Arizona
- St. Joseph's Hospital & Medical Center - Phoenix
California
- University of California, San Francisco - San Francisco
Idaho
- St. Luke's Regional Medical Center - Boise
New York
- Albany Medical Center - Albany
North Carolina
- Wake Forest University School of Medicine - Winston-Salem
Pennsylvania
- Allegheny General Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2019-03-12 |
| Est. Completion | 2028-12 |
What NCT03664609 shows while recruiting
NCT03664609 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 5,310-participant average among 297 other Parkinson Disease trials with a reported enrollment target.
The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation is the first listed.
NCT03664609 lists 19 locations in 9 states (Other, Florida, Arizona).
Frequently Asked Questions
What is clinical trial NCT03664609 about?
NCT03664609 is a clinical study titled "Deep Brain Stimulation (DBS) Retrospective Outcomes Study". The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
What is the current status of trial NCT03664609?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2019-03-12. Estimated completion is 2028-12.
What conditions does trial NCT03664609 study?
This clinical trial studies the following conditions: Parkinson Disease, Essential Tremor, Dystonia.
What interventions are being tested in trial NCT03664609?
The interventions under investigation include: Deep Brain Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03664609?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03664609 being conducted?
This trial has 19 study locations across Arizona, California, Florida, Idaho, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03664609's enrollment target sits among peer trials
5,000 5th of 297 higher than 293 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI